Pharmaceuticals in Brazil
- Pages: 40
- Published: May 2020
- Report Code: OHMF9724
Pharmaceuticals in Brazil industry profile provides top-line qualitative and quantitative summary information including: market share, market size (value 2015-19, and forecast to 2024). The profile also contains descriptions of the leading players including key financial metrics and analysis of competitive pressures within the market.
Key Highlights
– The pharmaceuticals market consists of ethical drugs only and does not include consumer healthcare or animal healthcare.
– The Brazilian pharmaceuticals market had total revenues of $29,550.0m in 2019, representing a compound annual growth rate (CAGR) of 6.6% between 2015 and 2019.
– Drug registration in Brazil with a new electronic system has been introduced under which drugs can be approved within six months, rather than up to two years, which has helped drive market growth.
– The Brazilian pharmaceutical market is one of the top emerging markets globally. In terms of revenue it is the seventh largest market in the world and the largest in Latin America.
Scope
– Save time carrying out entry-level research by identifying the size, growth, and leading players in the pharmaceuticals market in Brazil
– Use the Five Forces analysis to determine the competitive intensity and therefore attractiveness of the pharmaceuticals market in Brazil
– Leading company profiles reveal details of key pharmaceuticals market players’ global operations and financial performance
– Add weight to presentations and pitches by understanding the future growth prospects of the Brazil pharmaceuticals market with five year forecasts
Reasons to buy
- What was the size of the Brazil pharmaceuticals market by value in 2019?
- What will be the size of the Brazil pharmaceuticals market in 2024?
- What factors are affecting the strength of competition in the Brazil pharmaceuticals market?
- How has the market performed over the last five years?
- Who are the top competitiors in Brazil's pharmaceuticals market?
Companies mentioned
Sanofi SA
EMS Sigma Pharma
Ache Laboratorios Farmaceuticos SA
Table of Contents
List of Tables
List of Figures
Pricing
Discounts available for multiple purchases.